D-Gen
Owns technology for use in applications in this field including diagnostic tests and potential therapeutics.
Financials
Estimates*
USD | 2009 | 2020 |
---|---|---|
Revenues | <1m | <1m |
EBITDA | (<1m) | - |
% EBITDA margin | (89 %) | - |
Profit | (<1m) | - |
% profit margin | (159 %) | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
Total Funding | - |
Related Content
Recent News about D-Gen
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.